NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 11, 2026 — BioStem Technologies announces Q4 and full-year 2025 financial results conference call on March 24, 2026, featuring CEO and CFO insights into regenerative medicine advancements.
March 11, 2026 — NeuroOne Medical Technologies to present at Oppenheimer Healthcare Conference on March 17, 2026, featuring updates on its OneRF platform for brain treatment and pain management.
March 11, 2026 — Catalyst Crew Technologies appoints Dr. Kevin Rodan Levy as CEO to lead AI healthcare transformation focusing on emerging markets with telehealth and digital health solutions.
March 11, 2026 — American Heart Association warns sitting over 8 hours daily raises disease risk. Learn how 20-minute walks boost health, reduce stress, and improve longevity with tips from Heart.org/movemore.
March 11, 2026 — Earth Science Tech (ETST) operates a diversified portfolio in pharmaceutical, healthcare, and telemedicine markets, focusing on disciplined growth and regulatory compliance for long-term value creation.
March 11, 2026 — Stonegate updates coverage on Viemed Healthcare, reporting 21% revenue growth to $270.3M in FY25, record EBITDA, and a shift from ventilation to sleep services.
March 11, 2026 — Scientists identify common molecular program across three pediatric brain cancers, revealing shared biological weakness. Discovery opens path to therapies targeting multiple tumor types simultaneously.
March 11, 2026 — Oragenics explores CNS asset acquisitions to diversify its pipeline, complementing its AI collaboration and advancing ONP-002 for concussion treatment through clinical trials.
March 11, 2026 — NanoViricides announces NV-387 manufacturing completion and presentation at NIBA conference. Broad-spectrum antiviral advances toward Phase II monkeypox trial after successful safety study.
March 11, 2026 — CNS Pharmaceuticals announces a new strategy to acquire neurology and oncology assets, preparing legacy drugs for out-licensing to focus on high-value pipeline growth.
March 11, 2026 — GeoVax initiates global procurement talks for GEO-MVA mpox/smallpox vaccine candidate, aiming to diversify MVA vaccine supply through expedited Phase 3 study starting 2026.
March 11, 2026 — Sono-Tek secures $820K order for diagnostic medical device coating systems from existing customer scaling production. Ultrasonic coating technology enables precise thin film deposition for medical applications.
March 11, 2026 — Discover how Invisalign's clear aligners straighten teeth discreetly in 6-18 months. Vancouver's PacificWest Dental offers certified treatment with over 25 years experience.
March 11, 2026 — Dr. Maakan Taghizadeh earns 2026 Castle Connolly Top Doctor honor for third year, highlighting his plastic surgery expertise at U Plastic Surgery & Aesthetics with a holistic patient care approach.
March 11, 2026 — The Dairy Alliance partners with GHSA to provide real dairy milk to student-athletes at Georgia basketball championships, promoting recovery nutrition and community support.
March 11, 2026 — Dr. Joseph Cruise earns 2026 Castle Connolly Top Doctor honor for plastic surgery expertise in gynecomastia and facial rejuvenation, recognized by peer physicians for quality care.
March 11, 2026 — The Dairy Alliance supports TSSAA basketball athletes with real dairy milk for recovery, highlighting nutrition benefits and community partnerships in Tennessee.
March 10, 2026 — Soligenix receives UK Promising Innovative Medicine designation for SGX945 (dusquetide) to treat Behcet's Disease, a rare inflammatory disorder. Phase 2 data shows potential advantage over existing treatments.
March 10, 2026 — HeartBeam partners with Mount Sinai to develop AI-ECG algorithms using 3D cardiac monitoring technology, aiming to revolutionize remote patient care and preventive cardiology.
March 10, 2026 — LIXTE Biotechnology acquires Liora Technologies and its LiGHT proton therapy system, combining pharmaceutical innovation with advanced cancer treatment technology to improve patient outcomes.